Arthritis Treatment Pain Relief Taking Proton Pump Inhibitors When You Have Arthritis By Carol Eustice Carol Eustice Facebook Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis. Learn about our editorial process Updated on April 19, 2021 Learn more</a>." data-inline-tooltip="true"> Medically reviewed Verywell Health articles are reviewed by board-certified physicians and healthcare professionals. These medical reviewers confirm the content is thorough and accurate, reflecting the latest evidence-based research. Content is reviewed before publication and upon substantial updates. Learn more. by Grant Hughes, MD Medically reviewed by Grant Hughes, MD LinkedIn Grant Hughes, MD, is board-certified in rheumatology and is the head of rheumatology at Seattle's Harborview Medical Center. Learn about our Medical Expert Board Print Proton pump inhibitors, also called PPI drugs, are a class of drugs that are prescribed to treat heartburn, GERD (gastroesophageal reflux disease), ulcers, or other conditions associated with excess stomach acid. Proton pump inhibitors work by blocking an enzyme that is necessary for making acid in the stomach. By blocking the enzyme, acid production decreases. patrickheagney / Getty Images How Proton Pumps Work The proton pump is a molecule found in some cells of the stomach (parietal cells). Acting as a molecular machine, the proton pump takes a non-acidic potassium ion out of the stomach and replaces it with an acidic hydrogen ion. By putting hydrogen ions into your stomach, the proton pump increases the acidity of your stomach contents. Stomach acid is necessary to help break down food and aid digestion. Too much acid, though, can irritate the esophagus, causing indigestion or heartburn, and it can slow the healing of stomach ulcers. When excess acid becomes problematic, proton pump inhibitor drugs are often prescribed to shut down the proton pump. Why Some People With Arthritis Are Prescribed PPIs Many people with arthritis take nonsteroidal anti-inflammatory drugs (NSAIDs) to control inflammation and pain associated with their joint disease. While NSAIDs are often an effective arthritis treatment, the drugs are associated with gastrointestinal toxicity. This complication is largely due to prostaglandin inhibition by NSAIDs. People taking high dose NSAIDs or multiple NSAIDs, elderly people, or those with a history of peptic ulcer disease or gastrointestinal bleeding are at high risk for complications from NSAIDs. To lower the risk of gastrointestinal complications, people with arthritis may be advised to take a COX-2 inhibitor (e.g., Celebrex), or a traditional NSAID (e.g., naproxen, ibuprofen) with misoprostol or a proton pump inhibitor.Misoprostol has to be taken multiple times a day, can cause diarrhea, and may cause miscarriages, premature labor, or birth defects—so, PPI drugs are typically preferred. There's also Vimovo, a drug which combines an NSAID (naproxen) and a PPI (esomeprazole) in one pill. The combination of a PPI drug with an NSAID is not necessary in all cases. PPI drugs have actually become overused. PPI drugs, heavily advertised and promoted to both consumers and healthcare providers, have been used to treat mild stomach upset or heartburn when over-the-counter remedies, including antacids (Maalox, Mylanta, TUMS) or H2 blockers (Tagamet or Pepcid), would be sufficient. There are conservative guidelines that help manage NSAID toxicity: Take only one NSAID at a time, not multiple NSAIDs. Use the lowest effective dose of NSAID and for the shortest duration possible. Do not use NSAIDs when other treatment options work (analgesics, intra-articular injection). Take your NSAID with food. Don't ignore gastrointestinal symptoms; discuss with your healthcare provider. People with renal insufficiency, peptic ulcer disease, gastrointestinal bleeding, aspirin/NSAID hypersensitivity, uncontrolled hypertension, or cardiovascular disease should avoid NSAIDs. Availability PPI drugs are available both over-the-counter and by prescription only, depending on which you choose. According to Consumer Reports, the drugs are essentially equivalent in terms of effectiveness and safety but differ in cost. Omeprazole (Prilosec, Prilosec OTC) Lansoprazole (Prevacid, Prevacid 24 hr) Omeprazole/sodium bicarbonate (Zegerid, Zegerid OTC) Pantoprazole (Protonix) Esomeprazole (Nexium) Dexlansoprazole (Kapidex) Rabeprazole (Aciphex) Safety Concerns Aside from common side effects (headache, diarrhea), there have been certain safety concerns associated with PPI drugs, such as: An increased risk of infectionIncreased risk of infection with the bacteria Clostridium difficile which causes severe diarrheaIncreased risk of bone fractures, including hip fracture, with longterm useReduced effectiveness of Plavix (clopidogrel) to thin the bloodPossible interaction and lower effectiveness of other drugs and supplements Bottom Line No differently than for any other drug, the benefits and risks of PPIs must be weighed in each individual case. Some people may not require PPI drugs to manage mild to moderate heartburn or GERD, even though they have been prescribed the drugs. Don't stop the drugs without discussing it with your healthcare provider first. Stopping suddenly may actually increase symptoms. People with arthritis may be able to decrease the risk of gastrointestinal toxicity associated with NSAID use without taking PPI drugs. Remember, even if PPI drugs are warranted for your specific condition, safe use implies only taking the drug for as long as it is necessary. 11 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 2018 Apr;24(2):182-196. doi:10.5056/jnm18001 Herszényi L, Bakucz T, Barabás L, Tulassay Z. Pharmacological approach to gastric acid suppression: past, present, and future. Dig Dis. 2020;38(2):104-111. doi:10.1159/000505204 Elias P, Castell D. The role of acid suppression in Barrett’s esophagus. The American Journal of Medicine. 2017 May;130(5):525-529. doi:10.1016/j.amjmed.2016.12.032 Sostres C, Gargallo C, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2013 Jul;15(3):1-8. doi:10.1186/ar4175 Maseda D, Ricciotti E. NSAID–gut microbiota interactions. Front Pharmacol. 2020 Aug;11(1):1-13. doi:10.3389/fphar.2020.01153 Shroukh W, Steinke D, Willis S. Risk management of teratogenic medicines: a systematic review. Birth Defects Research. 2020 Sep;112(20):1755-1786. doi:10.1002/bdr2.1799 Heidelbaugh J, Kim A, Chang R, Walker P. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012 Jul;5(4):219-232. doi:10.1177/1756283X12437358 Lund L, Reilev M, Hallas J, et al. Association of nonsteroidal anti-inflammatory drug use and adverse outcomes among patients hospitalized with influenza. JAMA Netw Open. 2020 Jul;3(7):1-11. doi:10.1001/jamanetworkopen.2020.13880 Consumer Reports. Using the proton pump inhibitors to treat heartburn and stomach acid reflux. Jaynes M, Kumar A. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf. 2018 Nov;10(1):1-10. doi:10.1177/2042098618809927 Helgadottir H, Bjornsson ES. Problems associated with deprescribing of proton pump inhibitors. Int J Mol Sci. 2019 Nov;20(21):5469. doi:10.3390/ijms20215469 See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit